With no major difference for the quarter endedMarch 2026 , the total revenue stood at Rs. 6316.80 millions.The Company's Net profit for the March 2026 quarter have declined marginally to Rs. 449.60 millions as against Rs. 614.80 millions reported during the corresponding quarter ended.A decline of 801.00 millions was observed in the OP in the quarter ended March 2026 from 903.70 millions on QoQ basis.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202603	202503	% Var	202603	202503	% Var	202603	202503	% Var
Sales	6316.80	6229.60	1.40	22603.90	21736.50	3.99	22603.90	21736.50	3.99
Other Income	8.30	17.10	-51.46	25.90	135.80	-80.93	25.90	135.80	-80.93
PBIDT	801.00	903.70	-11.36	2633.30	2762.30	-4.67	2633.30	2762.30	-4.67
Interest	65.90	74.80	-11.90	263.80	296.80	-11.12	263.80	296.80	-11.12
PBDT	735.10	828.90	-11.32	2369.50	2465.50	-3.89	2369.50	2465.50	-3.89
Depreciation	149.50	122.10	22.44	556.40	477.90	16.43	556.40	477.90	16.43
PBT	585.60	706.80	-17.15	1813.10	1987.60	-8.78	1813.10	1987.60	-8.78
TAX	136.00	92.00	47.83	120.90	414.50	-70.83	120.90	414.50	-70.83
Deferred Tax	-14.00	-5.00	180.00	48.60	35.00	38.86	48.60	35.00	38.86
PAT	449.60	614.80	-26.87	1692.20	1573.10	7.57	1692.20	1573.10	7.57
Equity	912.70	912.70	0.00	912.70	912.70	0.00	912.70	912.70	0.00
PBIDTM(%)	12.68	14.51	-12.59	11.65	12.71	-8.33	11.65	12.71	-8.33

Aarti Drugs Ltd.